Developmental hemostasis: Recommendations for laboratories reporting pediatric samples

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 2, 2012, Pages 298-300

  Ignjatovic, V ^a,b   Kenet, G ^c,d   Monagle, P ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SHEBA MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; COLLAGEN; FIBRINOGEN; REAGENT; THROMBIN; VON WILLEBRAND FACTOR;

AGE; ARTICLE; BLOOD CLOTTING; DIAGNOSTIC ERROR; HEALTH CARE COST; HEMOSTASIS; HUMAN; LABORATORY DIAGNOSIS; NEWBORN CARE; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; REFERENCE VALUE; THROMBOELASTOGRAPHY;

AGE FACTORS; BLOOD COAGULATION TESTS; CALIBRATION; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; HEMATOLOGY; HEMOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS;

EID: 84856513766     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04584.x     Document Type: Article

References (25)

1. Andrew M. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-72.
2. Andrew M, Paes B, Johnston M. Development of the haemostatic system in the neonate and young infant. J Pediatr Hematol Oncol 1990; 12: 95-104.
3. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005.
4. Monagle P, Ignjatovic V, Savoia H. Haemostasis in neonates and children: pitfalls and dilemmas. Blood Rev 2010; 24: 63-8.
5. Beverley DW, Inwood MJ, Chance G, Schaus M, O'Keefe B. "Normal" haemostasis parameters: a study in a well-defined inborn population of preterm infants. Early Hum Dev 1984; 9: 249-57.
6. Boos J, Pollmann H, Dominick HC. Vitamin K-dependent coagulation parameters during the first six days of life: incidence of PIVKA II in newborns. Pediatr Hematol Oncol 1989; 6: 113-9.
7. Carcao MD, Blanchette VS, Dean JA, He L, Kern MA, Stain AM, Sparling CR, Stephens D, Ryan G, Freedman J, Rand ML. The Platelet Function Analyzer (PFA-100[R]): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 1998; 101: 70-3.
8. Chan KL, Summerhayes RG, Ignjatovic V, Horton SB, Monagle PT. Reference values for kaolin-activated thromboelastography in healthy children. Anesth Analg 2007; 105: 1610-3.
9. Flanders MM, Crist RA, Roberts WM, Rodgers GM. Pediatric reference intervals for ten coagulation assays. Blood 2004; 104: abstract #2988.
10. Mitsiakos G, Papaioannou G, Papadakis E, Chatziioannidis E, Karagianni P, Giougi E, Evdoridou J, Malindretos P, Athanasiou M, Athanassiadou F, Nikolaidis N. Haemostatic profile of full-term, healthy, small for gestational age neonates. Thromb Res 2008; 124: 288-91.
11. Monagle P, Barnes C, Ignjatovic V, Furmedge J, Newall F, Chan A, DeRosa L, Hamilton S, Ragg P, Robinson S, Auldist A, Crock C, Roy N, Rowlands S. Developmental haemostasis: impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95: 362-72.
12. Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88: 900-6.
13. Ries M, Klingeand J, Rauch R. Age-related reference values for activation markers of the coagulation and fibrinolytic systems in children. Thromb Res 1997; 85: 341-4.
14. Salonvaara M, Riikonen P, Kekomäki R, Vahtera E, Mahlamäki E, Halonen P, Heinonen K. Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants. Arch Dis Child 2003; 88: F319-23.
15. Sosothikul D, Seksarn P, Lusher JM. Pediatric reference values for molecular markers in hemostasis. J Pediatr Hematol Oncol 2007; 29: 19-22.
16. Bartle K, Dorsch E, Lill H, Ziegenhorn J. Determination of the biological activity of heparin by use of a chromogenic substitute. Thromb Haemost 1980; 42: 1446-51.
17. Holm HA, Abildgaard U, Kalvanes S, Anderssen N, Anker G, Arnesen KG, Blikom D, Drivener A. The antithrombotic effect of heparin in deep venous thrombosis: relation to four heparin assays. Acta Med Scand 1984; 216: 287-93.
18. Ignjatovic V, Summerhayes R, Gan A, Than J, Chan A, Cochrane A, Bennett M, Horton S, Shann F, Lane G, Ross-Smith M, Monagle P. Monitoring unfractionated heparin(UFH) therapy: which anti factor Xa is appropriate? Thromb Res 2007; 120: 347-51.
19. Mitchell LG, Vegh P. Conventional chromogenic heparin assays are influenced by patient's endogenous plasma Antithrombin levels. Klin Padiatr 2010; 222: 164-7.
20. Summerhayes R, Ignjatovic V, Hall M, Monagle P. Age-related reference ranges for Neoplastine R (PT) and Cephascreen (APTT) in healthy children. J Thromb Haemost 2007; 5. P-M-105.
21. Michelson AD. Platelet function in the newborn. Semin Thromb Hemost 1998; 24960: 507-12.
22. Cvirn G, Gallistl S, Muntean W. Effects of Antithrombin and protein C on thrombin generation in newborn and adult plasma. Thromb Res 1999; 93: 183-90.
23. Strauss T, Levy-Shraga Y, Ravid B, Schushan-Eisen I, Maayan-Metzger A, Kuint J, Kenet G. Clot formation of neonates tested by thromboelastography correlates with gestational age. Thromb Haemost 2010; 103: 344-50.
24. Chan KL, Summerhayes RG, Ignjatovic V, Horton SB, Monagle PT. Reference values for kaolin-activated thromboelastography in healthy children. Anesth Analg 2007; 105: 1610-3.
25. Olson JD, Arkin CF, Brandt JT, Cunningham MT, Giles A, Koepke JA, Witte DL. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy. Arch Pathol Lab Med 1998; 122: 782-98.